skills/pharmolix/openbiomed/single-cell-multi-omics-analysis-scvi/Snyk

single-cell-multi-omics-analysis-scvi

Pass

Audited by Snyk on Mar 25, 2026

Risk Level: LOW

Full Analysis

No issues detected.

Audit Metadata

Risk Level

LOW

Analyzed

Mar 25, 2026, 06:01 AM